Skip to main content

  • Search
  • Contact
  • Learning Center
  • Donate
  • About
    • Acknowledgements & Partners
    • Board of Directors
    • Our Staff
  • Our Work
    • NCSD Projects
    • Partnerships & Collaborations
    • Federal & State Policy
    • Clinic+: The STD and Sexual Health Clinic Initiative
    • Disease Intervention
    • Technical Assistance
  • NCSD Connect
  • Get Involved
    • NCSD Membership
    • Job Board
    • NCSD Member Profile
    • Explore Resources
    • Share Your Story
  • Resources
  • Events
  • News & Announcements
> News & Announcements > NCSD Highlights Importance of CDC Guidelines on Doxycycline as STI PEP 
Press Release

NCSD Highlights Importance of CDC Guidelines on Doxycycline as STI PEP 

Release Date
October 2, 2023

NCSD Highlights Importance of CDC Guidelines on Doxycycline as STI PEP 

For Immediate Release: October 2, 2023
Contact: Elizabeth Finley, [email protected], 919-749-7309   

Washington, D.C. — On Monday, the Centers for Disease Control and Prevention (CDC) released a draft guidelines on doxycycline as post-exposure prophylaxis (PEP) for sexually transmitted infections (STIs.) Doxycycline as STI PEP gives patients a new option to use common antibiotic – doxycycline – within 72 hours after sex to prevent bacterial STIs. David C. Harvey, executive director of the National Coalition of STD Directors (NCSD) released the following statement:  

“New innovations to prevent STIs are rare. Research showing that taking doxycycline within 72 hours after sex can prevent gonorrhea, chlamydia, and syphilis is one of the biggest game changers in STI prevention in a decade.” 

“As soon as research demonstrated the effectiveness of doxycycline as STI PEP more than a year ago, health department STI programs and the nation’s largest STI clinics started offering it to prevent STIs and the negative health consequences of having an STI. Today’s draft guidelines from the CDC are a critical next step toward helping patients get access to this STI prevention tool by ensuring health systems can offer doxycycline as STI PEP and insurers cover the cost to fight an out-of-control STI epidemic in America. “ 

“The stakes are high as STIs continue to rise to historic levels for the 9th straight year. We need to capitalize on every opportunity we have to prevent new infections. We’re encouraged to see the CDC move forward with updating the STI treatment and prevention guidelines to match what is already going on in health departments and clinics across the nation and to make this drug available to those who need it.”

“The release of today’s draft guidelines is an important step toward ensuring every person who needs access to doxycycline as STI PEP can get access to it, but this alone won’t end America’s STI epidemic. The Biden Administration and Congress must do everything in their power to fund STI prevention programs, including those implementing this new prevention strategy, and provide the resources necessary to expand STI public health prevention, care, and research programs,” said David C. Harvey, Executive Director of the National Coalition of STD Directors.  

Visit the Doxy as STI Command Center for Implementation Resources

Read this next:

Press Release

Latest STI Data Emphasizes Urgent Need to Invest in Lifesaving Congenital Syphilis Programs

November 12, 2024
Policy Statement Press Release

Following Historic Election Results, NCSD Urges New Efforts to Control STIs and End the HIV Epidemic 

November 8, 2024
Press Release

United States STI Directors Warn of Lack of Mpox Preparedness & Funding as WHO Declares Public Health Emergency 

August 14, 2024
Become an NCSD Member! Learn more here.
  • About
    • Our Staff
    • Board of Directors
    • Acknowledgements & Partners
  • Our Work
    • Member Services
    • NCSD Projects
    • Federal & State Policy
    • Technical Assistance
    • Partnerships & Collaborations
    • DIS
    • Clinic+: The STD and Sexual Health Clinic Initiative
  • Get Involved
    • Become a Member
    • Find a Job
    • Explore Resources
    • Share Your Story
  • Resources
  • News & Announcements
  • Events
  • Learning Center
  • Get in Touch
  • Organizational Financial Statements
  • Donate
© Copyright NCSD 2025.
Privacy Policy Credits